ROBERT BAKER: Open Payments
NPI 1689225427 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,858 in 35 payments from 7 companies in 2025. Trend: 2023 $1,519 · 2024 $1,803 · 2025 $1,858
Food & beverage: $1,858
| Company | Payments | Amount |
|---|---|---|
| Alpha Cognition USA, Inc. | 2 | $528 |
| Teva Pharmaceuticals USA, Inc. | 9 | $456 |
| E.R. Squibb & Sons, L.L.C. | 4 | $306 |
| Otsuka America Pharmaceutical, Inc. | 8 | $251 |
| Neurocrine BioSciences, Inc. | 5 | $141 |
| Lundbeck LLC | 6 | $136 |
| Janssen Pharmaceuticals, Inc | 1 | $41 |
Products named: Zunveyl, AUSTEDO XR, REXULTI, COBENFY, INGREZZA, INVEGA SUSTENNA, UZEDY.
Industry payments across CA — which companies pay providers there.
